Detalles de la búsqueda
1.
Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258181
2.
Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-482592
3.
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20237206
4.
Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21258332
5.
Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Measure SARS-CoV-2 Humoral Immunogenicity
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21261156
6.
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination in British Columbia, Canada: a Prospective Cohort Study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280429
7.
Antibody reactivity to SARS-CoV-2 in adults from the Vancouver metropolitan area, Canada
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20206664
Resultados
1 -
7
de 7
1
Próxima >
>>